Hudson Bay Capital Management »

Verve Therapeutics shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in Verve Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Verve Therapeutics held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verve Therapeutics by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2025-06-30 $43M 3.8M 11.23
2023-06-30 $422k 23k 18.75
2023-03-31 $418k 29k 14.42

More positions owned by Hudson Bay Capital Management

NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Amazon Call Option (AMZN)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Netflix Call Option (NFLX)
Berkshire Hathaway Inc Del Cl B New Call Option (BRK.B)
Advanced Micro Devices Put Option (AMD)
Ishares Bitcoin Trust Etf Shs Ben Int Call Option (IBIT)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Strategy Cl A New Call Option (MSTR)
Robinhood Mkts Com Cl A Call Option (HOOD)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Dollar Tree Call Option (DLTR)

View all positions for Hudson Bay Capital Management

Top funds holding Verve Therapeutics

XTX Topco
Greenland Capital Management
DekaBank Deutsche Girozentrale
Skopos Labs
IFP Advisors
Advisor Group Holdings

View all funds holding Verve Therapeutics